Dexcom G series

1 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Abbott vs. Dexcom: Which CGM Leader Offers Better Value in 2024?

Abbott offers diversified healthcare exposure with dividend income; Dexcom provides pure CGM growth but faces GLP-1 drug competition and concentration risk.
ABTDXCMdividend stockshealthcare stocks